Mr. Robert Thast reports

IZOTROPIC AFRICA LAUNCHES OPERATIONS IN CASABLANCA

Izotropic Corp. has launched Izotropic Africa in Casablanca, Morocco, and has appointed Mohammed Sair as general manager.

Advancing regional operations and market deployment across Africa and the GCC

Izotropic Africa will operate across 38 African countries and the GCC countries (Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain), and is supported by an established and active network of government stakeholders and ministries of health, major hospital groups and diagnostic networks, clinical research institutions, and industrial and financial partners.

Casablanca has been selected as the regional headquarters due to its logistics infrastructure, industrial capacity, and connectivity across Africa, Europe and the Middle East. From this base, Izotropic Africa is co-ordinating strategic management and regional co-ordination, regulatory, and clinical documentation across jurisdictions, training, education and support programs, software deployment and platform updates, and co-ordination of clinical, institutional and partner engagement.

Izotropic Africa is advancing localized manufacturing and assembly opportunities in Morocco, strategic industrial partnerships to support regional scaling and engagement with regional investment funds focused on health care infrastructure. Izotropic Africa intends to pursue CE Mark approval for IzoView in Europe, leveraging Morocco as a strategic operational base with preliminary discussions already initiated with a notified body to support the European Union approval process, alongside regulatory engagement across African and GCC markets.

12-month execution plan

Discussions are already under way with several major hospital groups and health care organizations. A lease has been executed for Izotropic Africa's headquarters.

Over the next 12 months, Izotropic Africa will focus on introducing IzoView to established medical networks across target countries, conducting clinical and technical presentations with Izotropic teams, engaging leading hospitals to secure pilot and early adopter sites, advancing commercial initiatives and structured sales programs, and progressing regulatory pathways across multiple jurisdictions.

With Izotropic Africa now operational, the company is advancing formalization of regional agreements, deployment of initial clinical systems, expansion of institutional and government partnerships, acceleration of regulatory approvals, and development of industrial and funding partnerships.

Upon regulatory approval, Izotropic Africa projects 40 IzoView sales in year 1, growing to 300 cumulative sales by year 5.

Letter agreement amendment

Further to the company's Feb. 18 press release, Izotropic and Izotropic Africa have entered into a definitive letter agreement with amendments and are extending the deadline to finalize the formal agreement to June 30, 2026.

The extension reflects continuing engagements and scheduled meetings with hospital groups, health care organizations and funding entities in connection with the development of Izotropic Africa's regional operations, and provides additional time to finalize certain material components of the formal agreement, specifically those related to the shareholder and master distributor arrangements.

Izotropic Africa's general manager comments

"Since the initial announcement of Izotropic's expansion, we have established a strong operational foundation and initiated advanced discussions with governments, health care institutions, and strategic partners across Africa and the GCC.

"This is not a conventional market entry, but the development of a long-term health care infrastructure platform designed to address significant unmet needs across the region. There is strong alignment with governments and health care institutions seeking to expand access to advanced diagnostics, and we are working alongside partners to advance these initiatives.

"We believe this represents a critical inflection point, where co-ordinated deployment of advanced imaging technologies has the potential to redefine standards of care," stated Mohammed Sair.

About Mohammed Sair

Mr. Sair is a senior executive with over 25 years of international experience across Africa, the Middle East and Europe, specializing in health care infrastructure, medical device distribution and regulated health-sector operations. He has led the establishment and expansion of regional health care platforms, with a proven record in market entry strategy, regulatory navigation and large-scale project execution. Mr. Sair previously served as founder and chief executive officer of a Casablanca-based medical device and hospital engineering company, where he oversaw major health care deployments, strategic partnerships and compliance frameworks. His experience spans health care logistics, industrial operations and infrastructure development, with deep expertise in building partnerships with government institutions, hospital networks and private-sector stakeholders across multiple African markets. Mr. Sair holds a mechanical engineering degree and a marine chief engineer diploma, and is fluent in Arabic and French, with professional proficiency in English.

We seek Safe Harbor.